BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32784343)

  • 1. End-tidal to Arterial Gradients and Alveolar Deadspace for Anesthetic Agents.
    Peyton PJ; Hendrickx J; Grouls RJE; Van Zundert A; De Wolf A
    Anesthesiology; 2020 Sep; 133(3):534-547. PubMed ID: 32784343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gas Phase Diffusion Does Not Limit Lung Volatile Anesthetic Uptake Rate.
    Peyton PJ
    Anesthesiology; 2022 Aug; 137(2):176-186. PubMed ID: 35503977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ideal alveolar gas defined by modal gas exchange in ventilation-perfusion distributions.
    Peyton PJ
    J Appl Physiol (1985); 2021 Dec; 131(6):1831-1838. PubMed ID: 34672764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimum alveolar anesthetic concentration of volatile anesthetics in normal and cardiomyopathic hamsters.
    Vivien B; Langeron O; Coriat P; Riou B
    Anesth Analg; 1999 Mar; 88(3):489-93. PubMed ID: 10071992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circuit absorption of halothane, isoflurane, and sevoflurane.
    Eger EI; Ionescu P; Gong D
    Anesth Analg; 1998 May; 86(5):1070-4. PubMed ID: 9585300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of the inspiratory-arterial isoflurane partial pressure difference.
    Landon MJ; Matson AM; Royston BD; Hewlett AM; White DC; Nunn JF
    Br J Anaesth; 1993 Jun; 70(6):605-11. PubMed ID: 8329250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial to inspired partial pressure ratio of halothane, isoflurane, sevoflurane and desflurane in rats.
    Holdcroft A; Bose D; Sapsed-Byrne SM; Ma D; Lockwood GG
    Br J Anaesth; 1999 Oct; 83(4):618-21. PubMed ID: 10673881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of desflurane, isoflurane, and halothane in humans.
    Yasuda N; Lockhart SH; Eger EI; Weiskopf RB; Johnson BH; Freire BA; Fassoulaki A
    Anesthesiology; 1991 Mar; 74(3):489-98. PubMed ID: 2001028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial pressure and cardiopulmonary variables during isoflurane or sevoflurane anesthesia at various minimum alveolar concentration multiples in normocapnic dogs.
    Chohan AS; Greene SA; Keegan RD; Grubb TL; Chen AV
    Am J Vet Res; 2013 Mar; 74(3):369-74. PubMed ID: 23438110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-tidal sevoflurane and halothane concentrations during simulated airway occlusion in healthy humans.
    Talbot NP; Farmery AD; Dorrington KL
    Anesthesiology; 2009 Aug; 111(2):287-92. PubMed ID: 19568159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of anaesthetic gases and vapours.
    Lin CY
    Anaesth Intensive Care; 1994 Aug; 22(4):363-73. PubMed ID: 7978196
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of expiratory desflurane and sevoflurane concentrations in lung-healthy patients utilizing cardiac output and alveolar ventilation matched pharmacokinetic models: A comparative observational study.
    Weber J; Mißbach C; Schmidt J; Wenzel C; Schumann S; Philip JH; Wirth S
    Medicine (Baltimore); 2021 Feb; 100(6):e23570. PubMed ID: 33578509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Global Ventilation to Perfusion Ratio, for Normal Lungs, on Desflurane and Sevoflurane Elimination Kinetics.
    Baumgardner JE; Kretzschmar M; Kozian A; Hachenberg T; Schilling T; Larsson A; Hedenstierna G
    Anesthesiology; 2021 Dec; 135(6):1042-1054. PubMed ID: 34731232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity modestly affects inhaled anesthetic kinetics in humans.
    Lemmens HJ; Saidman LJ; Eger EI; Laster MJ
    Anesth Analg; 2008 Dec; 107(6):1864-70. PubMed ID: 19020131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of One-Lung Ventilation on Blood Sevoflurane and Desflurane Concentrations.
    Biricik E; Karacaer F; Güneş Y; Dağlıoğlu N; Efeoğlu P; Ilgınel M; Avcı A; Özcengiz D
    J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):442-449. PubMed ID: 30049524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lower solubility recommends the use of desflurane more than isoflurane, halothane, and enflurane under low-flow conditions.
    Hargasser S; Hipp R; Breinbauer B; Mielke L; Entholzner E; Rust M
    J Clin Anesth; 1995 Feb; 7(1):49-53. PubMed ID: 7772358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of 0.1 minimum alveolar concentration of sevoflurane, desflurane and isoflurane on dynamic ventilatory response to hypercapnia in humans.
    van den Elsen M; Sarton E; Teppema L; Berkenbosch A; Dahan A
    Br J Anaesth; 1998 Feb; 80(2):174-82. PubMed ID: 9602581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflurane inhalation enhances increased physiologic deadspace volume associated with positive pressure ventilation and compromises arterial oxygenation.
    Praetel C; Banner MJ; Monk T; Gabrielli A
    Anesth Analg; 2004 Oct; 99(4):1107-1113. PubMed ID: 15385359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood flow at 0.5 and 1.0 minimal alveolar concentrations of desflurane or sevoflurane compared with isoflurane in normoventilated pigs.
    Holmström A; Akeson J
    J Neurosurg Anesthesiol; 2003 Apr; 15(2):90-7. PubMed ID: 12657993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous loss of desflurane, isoflurane, and halothane in humans.
    Fassoulaki A; Lockhart SH; Freire BA; Yasuda N; Eger EI; Weiskopf RB; Johnson BH
    Anesthesiology; 1991 Mar; 74(3):479-83. PubMed ID: 2001027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.